ABCL
AbCellera Biologics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.49
+0.02 ▲ +0.58%
🌙 3월 13일 7:39 PM ET (한국 3/14 08:39)
$3.49
+0.00 +0.03%
| Index | - | P/E | - | EPS (ttm) | -0.49 | Insider Own | 23.33% | Shs Outstand | 0.30B | Perf Week | 1.16% |
| Market Cap | 1.06B | Forward P/E | - | EPS next Y | -1.75% | Insider Trans | - | Shs Float | 0.23B | Perf Month | 11.5% |
| Enterprise Value | 0.64B | PEG | - | EPS next Q | -0.16 | Inst Own | 36.58% | Short Float | 22.08% | Perf Quarter | -7.43% |
| Income | -0.15B | P/S | 14.08 | EPS this Y | -31.97% | Inst Trans | 2.15% | Short Ratio | 12.08 | Perf Half Y | -24.3% |
| Sales | 0.08B | P/B | 1.09 | EPS next 5Y | -16.76% | ROA | -10.78% | Short Interest | 51.32M | Perf YTD | 2.05% |
| Book/sh | 3.22 | P/C | 1.89 | EPS past 3/5Y | - | ROE | -14.47% | 52W High | -46.43% ($6.51) | Perf Year | 45.42% |
| Cash/sh | 1.85 | P/FCF | - | Sales past 3/5Y | -46.31% -20.27% | ROIC | -13.26% | 52W Low | 84.6% ($1.89) | Perf 3Y | -52.96% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 11.33% | Gross Margin | 61.64% | Volatility(W/M) | 5.51% 6.57% | Perf 5Y | -90.45% |
| Dividend TTM | - | EV/Sales | 8.53 | Sales Y/Y TTM | 160.55% | Oper. Margin | -288.98% | ATR (14) | 0.23 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 11.23 | EPS Q/Q | 74.24% | Profit Margin | -194.89% | RSI (14) | 49.72 | Recom | 1.29 |
| Dividend Gr. 3/5Y | - | Current Ratio | 11.32 | Sales Q/Q | 788.18% | SMA20 | 2.35% ($3.41) | Beta | 0.86 | Target Price | $9.2 |
| Payout | - | Debt/Eq | 0.15 | Earnings | 2000000 | SMA50 | -4.06% ($3.64) | Rel Volume | 0.49 | Prev Close | $3.47 |
| Employees | 562 | LT Debt/Eq | 0.14 | EPS/Sales Surpr. | 77.61% 572.89% | SMA200 | -14.23% ($4.07) | Avg Volume(3M) | 4.25M | Price | $3.49 |
| IPO | 2020/12/11 | Option/Short | Yes/Yes | Trades | 6742 | Volume | 2,067,055 | Change | 0.58% |
뉴스 로딩 중...